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Glutathione peroxidases (GPX), enzymes that catalyze the reduction of reactivc intermediates have been implicated in the 
action of several cytostatic drugs, T w o major types or G PX  have been found: a selenium-dependent form (SeGPX) which 
is active with both hydrogen peroxide and organic hydroperoxides, and a selenium-independent G P X  which is only active 
with organic hydroperoxides. SeGPX and total G PX  (tG PX ) activity were assayed in cytosolic fractions from malignant 
and adjacent normal tissue in 13 patients with oral/oropharyngeal, and 10 patients with laryngeal squamous cell 
carcinoma. Neck lymph node metastases were available from 2 and 5 o f  these patient respectively. Tum ors from the 
oral/oropharyngeal region contained significantly less SeGPX and tG PX  activity than laryngeal tumors. Primary 
oral/oropharyngeal and laryngeal tumors had lower SeGPX activities than the matched normal mucosa. tGPX activities 
were similar in norma! and tumor tissue. Metastases contained slightly more SeGPX and tG PX  activity than the matched 
tumor tissue. We conclude that the inherent anti-tum or drug resistance of hum an head and neck squam ous cell carcinoma 
is not mediated by increased glutathione peroxidase enzyme activity in the tum or tissue. Key words: glutathione peroxidase, 
head and neck cancer, drug resistance.
IN T R O D U C T IO N
Oral/oropharyngeal and laryngeal cancer account for 
2.1 and 1.3 cancer deaths respectively per 100,000 
inhabitants per year in T he  N etherlands (1), Early 
involvement of regional lym ph nodes tends to occur 
in patients with these types o f  cancers. C hem other­
apy, usually added for the trea tm en t of extensive 
disease, is of limited use due to either intrinsic resis­
tance or development of (m ultidrug) resistance d u r ­
ing treatment with anti-cancer drugs (2, 3).
The mechanisms involved in drug  resistance are 
poorly understood. In vitro studies with tu m or cell 
lines selected for resistance to com m only used 
chemotherapeutic agents showed that several interre­
lated mechanisms may be involved in the acquisition 
of the drug resistant phenotype, Decreased intracellu­
lar drug accumulation due to increased expression o f  
P170 glycoprotein, a drug  efflux pum p (4), increased 
repair of or tolerance to drug-induced dam age due to 
increased expression of D N A  topoisom erases (5), and  
increased metabolic drug inactivation by glutathione- 
consuming reactions (6 , 7) m ay all contribute  to resis­
tance.
Glutathione peroxidases (G P X ) are enzymes tha t 
catalyze the reduction o f  organic hydroperoxides 
(lipid hydroperoxides, D N A  hydroperoxides) and h y ­
drogen peroxide, intermediates implicated in the a c ­
tion of cytostatic drugs such as bleomycin or 
adriamycin (8 ,9). Two m ajo r  types o f  G PX  have
been found. One type contains selenium; this enzyme 
is active with bo th  organic hydroperoxides and hy­
drogen peroxide. The second type of G PX  consists of 
proteins tha t do  no t depend on selenium, and have 
negligible activity with hydrogen peroxide. This class 
comprises mainly glutathione S-transferases (10). All 
GPX-catalyzed reactions use reduced glutathione as a 
cofactor (10). In sarcom a (11) and other human cell 
lines ( 12) resistant to the anti-cancer drugs adri­
amycin or cisplatin, increased G P X  activity has been 
implicated as a mechanism o f  resistance. High G PX  
levels are also present in several refractory solid 
tumors, where they m ay be a barrier to effective 
treatm ent with chem otherapeutic  agents (13-15). In 
this study we examined the G PX  activity with hydro­
gen peroxide (selenium -dependent activity, SeGPX) 
and t-butylhydroperoxide (to tal activity, tGPX) as 
substrates, in tum or tissue and corresponding normal 
epithelium in patients with head and neck squamous 
cell carcinom a.
* Present affiliation: Department of Otorhinolaryngology, Head 
and Neck Surgery, University Hospital M aastricht, The N ether­
lands.
M A T E R IA L  A N D  M E T H O D S
Tissue samples
Twenty-three patients (22 men and i woman, median 
age 63 years, range 4 7 -7 4  years) with head, and neck 
squam ous cell carcinom a were operated on at the 
D epartm en t o f  O torhinolaryngology and Maxillofa­
cial Surgery o f  the St R ad b o u d  University Hospital. 
All patients received prim ary  surgical treatment. T u ­
m or localizations were oral cavity (n =  3), tongue 
(n — 6 ) o ropharynx  (/; = 4 )  and larynx (n =  10). One 
tum or was well differentiated, 19 tumors were modcr-
©  1995 Scandinavian University Press. ISSN 0001-6489
332 T. P, «ƒ. Mulder et al. Acta Otolaryngol (Stockh) 115
ately and 3 poorly differentiated. Representative parts (Table I). In comparison with normal oral/oropha- 
of tumor and adjacent normal mucosa were excised by ryngeal mucosa, normal laryngeal mucosa had higher
a pathologist. From 7 patients, samples of neck lymph 
node metastases were obtained at primary resection, 
All tissue samples obtained were frozen within 20 min 
after resection of the tumor, and were stored at 
— 70°C, Tissue fragments (10-100 mg) were thawed
SeGPX and tGPX activities, but the difference was 
statistically significant only for tGPX activity.
Tumors at both localizations contained less SeGPX 
activity than the corresponding normal tissues, and 
when data from the two localizations were combined
and homogenized on ice in 5 volumes of homogenizing the difference was significant (p < 0.05). tGPX activi- 
buffer (250 mM sucrose, 20 mM Tris-HCl, ImM  ties were similar in normal mucosae and primary
tumor tissues, both in the oral cavity and larynx.
Metastases had SeGPX activities similar to those in 
matched normal mucosae. tGPX activity in the
dithiothreitol, pH 7.4) using small glass-glass homog­
enizes. Homogenates were centrifuged at 150,000 x g 
at 4°C for 1 h. Supernatants (cytosolic fraction) were 
divided into portions and stored at — 70°C.
Assays
metastases was slightly higher in comparison with 
both primary tumors and normal mucosae, but the 
difference with respect to normal tissues was signifi-
Protein was assayed by the method of Lowry et aL cant only for metastases of oral/oropharyngeal tu- 
(16). Glutathione peroxidase enzyme activity was mors (Table I).
When SeGPX activity was plotted against tGPX 
activity for all 53 times samples analyzed, a regression 
line with a correlation coefficient of 0.90 (p <0.001) 
was obtained.
DISCUSSION
measured with hydrogen peroxide and t-butylhy- 
droperoxide (Sigma Chemical Company, St Louis,
MO, USA) as substrates, essentially as described by 
Howie et al. (14).
Statistical analysis
Data were calculated per mg total cytosolic protein
and expressed as the mean ± standard error of the tGPX activity was highly correlated with SeGPX
mean. Results for the different groups were compared activity, indicating that GPX activity in normal and
with Student’s /-test. The paired Student’s /-test was malignant tissue from human head and neck mucosa
used to evaluate differences between pairs of normal is mediated mainly by SeGPX. Howie et al. (14)
and malignant or normal and metastatic tissue. Corre- reported very similar results for normal and malig-
lations between the parameters were tested with Pear- nant human lung, colon and breast tissue, in which
son’s linear correlation procedure. Differences were tGPX activity also closely paralleled SeGPX activity.
considered significant if the p value was below 0.05.
RESULTS
Parise et al. (17) reported higher concentrations of 
glutathione and glutathione S-transferases in human 
head and neck squamous cell carcinomas in compari­
son with normal tissue. Glutathione S-transferases
Cytosolic fractions of squamous cell carcinomas from constitute a major part of selenium-independent GPX
the larynx contained significantly more SeGPX activ- activity (10), therefore higher tGPX activities might
ity and tGPX activity than fractions from compara- have been expected in these tumors. Significantly
ble tumors of the oral cavity, tongue and oropharynx higher SeGPX and tGPX activities in tumor tissues
Table I. Selenium-dependent glutathione peroxidase (SeGPX) and total glutathione peroxidase (tGPX) activity in 
cytosols o f primary tumors, corresponding normal mucosae and metastases from hitman head and neck squamous 
cell carcinoma
Tumor
localization
SeGPX activity 
(nmol/min/mg protein)
tGPX activity 
(nmol/min/mg protein)
Oral cavity, Normal mucosa (n == 13) 211 ±28 130 + 18
tongue and Tumor (n = 13) 156 ±  12 116 ±  9
oropharynx Metastasis (n — 2) 202 ±  45 172 ± 27c
Normal mucosa (n == 10) 273 +  40 200 + 29 u
Larynx Tumor (n = 10) 230 +  12b 198 ± 9 b
Metastasis (n — 5) 293 ± 32 244 +37
a p <0.05 vs. normal oral and oropharyngeal mucosa. 
b p < 0.001 vs. oral and oropharyngeal tumor tissue. 
c p <0.05 vs. normal oral and oropharyngeal mucosa.
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than in adjacent normal tissues have been reported in 
malignancies from breast (14), lung (13, 15), colon, 
stomach and kidney (14). The results of the present 
study contrast with reports of other solid tumors, as 
lower SeGPX activities and similar tGPX activities 
were found in human head and neck squamous cell 
carcinomas in comparison with adjacent normal tis­
sue. However, the combination of similar tGPX ac­
tivities and lower SeGPX activités indicates that 
Se-independent GPX activities (i,e. glutathione S- 
transferases) are increased in the primary tumors* 
Metastases had higher SeGPX and tGPX activities 
than the corresponding primary tumors, and mean 
values were very similar (SeGPX) or slightly above 
(tGPX) activities detected in the corresponding nor­
mal tissues, Janot et al. (18) assayed several principal 
drug- and carcinogen-metabolizing enzymes in pairs 
of tumor and adjacent normal tissue in the pyriform 
sinus of the larynx. Except for a decrease in epoxide- 
hydrolase and an increase in glutathione concentra­
tion in the tumors, these authors found no significant 
difference between normal and tumor tissues,
Our results also show that GPX activity in human 
head and neck squamous cell carcinoma varies with 
the localization of the tumor. Malignancies in the 
oral region contained significantly less SeGPX and 
tGPX activity than laryngeal tumors.
In conclusion, human head and neck squamous cell 
carcinomas contain less SeGPX activity and similar 
amounts of tGPX activity in comparison with adja­
cent normal tissues, Tumors in the oral cavity had 
significantly lower SeGPX and tGPX activities than 
laryngeal tumors. These results do not support the 
hypothesis that GPX plays a role in the intrinsic 
resistance of these tumors to anti-cancer drugs. Be­
cause both glutathione S-transferase enzyme activities 
(17) and Se-independent GPX activities (this study) 
are increased in human head and neck squamous cell 
carcinomas, further studies are indicated to examine 
the composition of glutathione S-transferase sub­
classes in these tumors.
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